A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients
Clinical trial NCT00002245 · COMPLETED
Trial details
- NCT number
- NCT00002245
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.